Rappta Therapeutics, a private biotech focused on developing anti-cancer drugs activating protein phosphatase 2A (PP2A), has ...

Iconovo AB, a developer of inhalable drugs based on proprietary inhalers and dry powder formulations, and Lonza, a healthcare ...

GSK plc has agreed to acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company dedicated to developing ...

ILC Dover, an Ingersoll Rand Business, has launched Sentinel XT Horizon, a new addition to the Sentinel XT line of Powered ...

Johnson & Johnson has agreed to acquire all outstanding shares of Intra-Cellular Therapies Inc., a biopharmaceutical company ...

Gilead Sciences Inc. and LEO Pharma have partnered to accelerate the development and commercialization of LEO Pharma’s small ...

Telix Pharmaceuticals Limited has entered into an asset purchase agreement with antibody engineering company ImaginAb Inc. to ...

Aragen, a global contract research, development and manufacturing organization, has secured a $100 million investment from ...

Alcami Corp., a contract development and manufacturing organization, announced the resignation of Bill Humphries. Alcami’s ...

Biohaven Ltd. and Merus N.V., have announced a research collaboration and license agreement to co-develop three novel bispecific antibody drug conjugates (ADCs), leveraging Merus’ Biclonics technology ...

Synthego granted global license to manufacture and distribute AZ's CRISPR gene editing enzyme, eSpOT-ON.

AbbVie and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd., entered an option to license agreement to ...